Data / Form D filings / NIIKI PHARMA INC
NIIKI PHARMA INC: Form D filings
NIIKI PHARMA INC, a biotechnology company in Hoboken, NJ, filed 4 Form D notices with the SEC between 2010 and 2011. The latest, on August 10, 2011, reports $1.7 million sold of a $6 million offering to 18 investors.
Find out what NIIKI PHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 80 RIVER STREET, SUITE 5D, Hoboken, NJ, 07030
- Phone
- (201) 238-2885
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1420996
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2011 | Amendment | $6,000,000 | $1,688,500 | $4,311,500 | 18 | Feb 23, 2011 | sec.gov |
| Mar 1, 2011 | New notice | $6,000,000 | $500,000 | $5,500,000 | 11 | Feb 23, 2011 | sec.gov |
| Jul 23, 2010 | Amendment | $7,000,000 | $5,000,000 | $2,000,000 | 25 | Jan 6, 2009 | sec.gov |
| Mar 11, 2010 | Amendment | $5,000,000 | $3,800,000 | $1,200,000 | 23 | Jan 6, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ali Ardakani | Executive Officer, Director | |
| Hooshmand Sheshbaradaran | Executive Officer, Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Aug 8, 2011 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NIIKI PHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.